• Corpus ID: 5675853

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

  title={Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.},
  author={Michael C. Alley and Dominic A. Scudiero and Anne P Monks and M L Hursey and Maciej Czerwiński and Donald L. Fine and Betty J. Abbott and Joseph G. Mayo and Robert H. Shoemaker and Michael R. Boyd},
  journal={Cancer research},
  volume={48 3},
For the past 30 years strategies for the preclinical discovery and development of potential anticancer agents have been based largely upon the testing of agents in mice bearing transplantable leukemias and solid tumors derived from a limited number of murine as well as human sources. The feasibility of implementing an alternate approach, namely combined in vitro/in vivo screening for selective cytotoxicity among panels of human tumor cell lines derived from a broad spectrum of human solid… 

Figures and Tables from this paper

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

A pilot-scale, in vitro, anticancer drug screen utilizing a panel of 60 human tumor cell lines organized into subpanels representing leukemia, melanoma, and cancers of the lung, colon, kidney, ovary, and central nervous system is described.

Application of Cell and Tissue Culture Systems for Anticancer Drug Screening

The modern in vitro models used to evaluate cytotoxic substances that inhibit the growth of tumor cells are described and their respective advantages and disadvantages are discussed.

A Nonclonogenic Cytotoxicity Assay Using Primary Cultures of Patient Tumor Cells for Anticancer Drug Screening

Primary cultures of cells from patients with chronic lymphocytic leukemia and ovarian carcinoma may be a useful and valuable model for anticancer drug screening as judged from correlation analysis.

Preclinical evaluation and phase I trials

In vitro screens, as currently employed, are ill-designed to demonstrate activity with drugs which require metabolic activation, drugs acting via the immune system and drugs with bell-shaped dose-response curves.

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

Ten human ovarian carcinoma cell lines studied as a potential in vitro screen for the development of novel anticancer platinum complexes showed that cisplatin, iproplatin and carboplatin elicit a very similar pattern of response in these lines whereas tetraplatin elicits a completely different response pattern.

Chemosensitivity testing of small cell lung cancer using the MTT assay.

A simple colorimetric test, the MTT assay, has been adapted for chemosensitivity testing of human small cell lung cancer cell lines, and fresh tumour samples, and sixteen different chemotherapeutic agents were found to be cytotoxic in this assay system.

Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony‐forming units, and xenografts

The potent activity of irofulven against ovarian tumors in vitro and in vivo supports the evaluation of its clinical activity in ovarian cancer.

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.

Disease-oriented panels of human tumor cell lines used by the National Cancer Institute for large-scale in vitro anticancer drug screening were evaluated for multidrug-resistant phenotype at the

Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts

The potent activity of irofulven against ovarian tumors in vitro and in vivo supports the evaluation of its clinical activity in ovarian cancer.



Application of a human tumor colony-forming assay to new drug screening.

The demonstrated sensitivity to most standard agents, discrimination of nontoxic compounds, reproducibility of survival values within assays and between laboratories, and evidence of ability to identify active compounds which were negative in the in vivo prescreen suggest that the human tumor colony-forming assay may be a valuable tool for antitumor drug screening.

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

An in vitro tumor-colony assay developed to measure sensitity of human-tumor stem cells to anticancer drugs shows sufficient promise to warrant larger-scale testing to determine its efficacy for selection of new agents and individualized cancer chemotherapy regimens.

Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines.

Hepatocyte:tumor cell cocultures may be well-suited for assessing the degree to which hepatic metabolism may activate or inactivate new anticancer drugs.

Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines.

A new in vitro cell line established from human large cell variant of oat cell lung cancer.

The cell line has maintained its morphological, karyotypic, chromosomal, and growth characteristics after transplantation to nude mice and appears to represent a propitious cell line for in vitro and in vivo biological and therapeutic studies of this type of lung cancer.

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.

Metastatic behavior of human tumor cell lines grown in the nude mouse.

Intrasplenic injection of tumor cells allowed the most dramatic overall expression of metastatic capacity in these cell lines, resulting in frequent and large metastases to liver, lungs, and the mesenteric, omental, and mediastinal lymph nodes.

Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.

The epithelial morphology of IGROV1 cells was retained during in vitro and in vivo passages, as judged by both the light and the electron microscopes, which make the cell line a suitable experimental model for the treatment of human ovarian carcinomas and for biological studies of human solid tumors.

Establishment of cross-resistance profiles for new agents.

The cross-resistance profiles of drug-resistant murine tumors to treatment with new drugs going into phase I-II trials should provide useful guides for patient selection for those trials, as well as indicating likely biochemical mechanism of action of new drugs with promising anticancer activity.